Pharma’s Paradox: Cure A Deadly Childhood Disease And Then Get Attacked On Price

Let’s begin to figure out how best to reward the innovators who are restoring life to patients. But let’s not denigrate the biopharmaceutical industry in doing so.

Read the full post at Forbes - Pharma & Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive